Cornercap Investment Counsel Inc Praxis Precision Medicines, Inc. Transaction History

Cornercap Investment Counsel Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$0.8 - $4.98 $121 - $756	152 Added 0.21%	73,127 $59,000
Q4 2022 Feb 13, 2023	BUY	$1.88 - $36.45 $432 - $8,383	230 Added 0.32%	72,975 $173,000
Q3 2022 Nov 14, 2022	BUY	$2.5 - $37.95 $131,842 - $2 Million	52,737 Added 263.58%	72,745 $165,000
Q2 2022 Aug 15, 2022	BUY	$1.75 - $11.34 $35,014 - $226,890	20,008 New	20,008 $49,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.54B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Cornercap Investment Counsel Inc with notifications on news.